Date created: | Last Updated:
:
DOI
Recreate DOI : Create with the first member (
Imad Abugessaisa
) in the member list
Creating DOI. Please wait...
Create DOI : Create with the first member ( Imad Abugessaisa ) in the member list
Category: Project
Description: While some old adults stay healthy and non-frail up to late in life, others experience multimorbidity and frailty often accompanied by a pro-inflammatory state. The underlying molecular mechanisms for those differences are still obscure. Here, we used gene expression analysis to understand the molecular underpinning between non-frail and frail individuals in old age. Twenty-four adults (50% non-frail and 50% frail) from InCHIANTI study were included. Total RNA extracted from whole blood were analyzed by Cap Analysis of Gene Expression (CAGE). CAGE identified transcription start site (TSS) and active enhancer regions. We identified a set of differentially expressed (DE) TSS and enhancer between non-frail and frail and male and female participants. Several DE TSS annotated as lncRNA (XIST and TTTY14) and Antisense RNAs (ZFX-AS1 and OVCH1-AS1). The promoter region chr6:366,786,54-366,787,97;+ was DE and overlapping the longevity CDKN1A gene. GWAS-LD enrichment analysis identifies overlapping LD-blocks with the DE regions with reported traits in GWAS catalog (isovolumetric relaxation time and urinary tract infection frequency). Furthermore, we used weighted gene co-expression network analysis (WGCNA) to identify changes of gene expression associated with clinical traits and identify key gene modules. We Performed functional enrichment analysis of the gene modules with significant trait/module correlation. One gene module showing a very distinct pattern in hub genes. PYGL was the top ranked hub gene between non-frail and frail. We predicted transcription factors binding sites (TFBS) and motifs activity. TF involved in age-related pathways (e.g., FOXO3, MYC) shows different expression patterns between non-frail and frail participants. Expanding the study of OVCH1-AS1 and PYGL may help understanding the mechanisms leading to loss of homeostasis that ultimately causes frailty.